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AbstrAct
Introduction Despite the introduction of new tests and 
guidelines for diagnosis of tuberculosis (TB), worldwide 
case detection rate of TB is still suboptimal. This could 
be in part explained by the poor implementation of TB 
diagnostic guidelines. We aim to identify, appraise and 
synthesise qualitative evidence exploring the barriers and 
facilitators to implementing TB diagnostic guidelines.
Methods and analysis A systematic review of qualitative 
studies will be conducted. Relevant electronic databases 
will be searched and studies included based on predefined 
inclusion criteria. We will also search reference lists, grey 
literature, conduct forward citation searches and contact 
relevant content experts. An adaptation of the Critical 
Appraisal Skills Programme tool will be used to assess the 
methodological quality of included studies. Two authors 
will review the search output, extract data and assess 
methodological quality independently, resolving any 
disagreements by consensus. We will use the thematic 
framework analysis approach based on the Supporting the 
Use of Research Evidence thematic framework to analyse 
and synthesise our data. We will apply the Confidence 
in the Evidence from Reviews of Qualitative research 
approach to transparently assess our confidence in the 
findings of the systematic review.
Ethics and dissemination This protocol has been 
registered with the International Prospective Register of 
Systematic Reviews (PROSPERO), registration number 
CRD42016039790
Trial registration number PROSPERO 2016: 
CRD42016039790. Available from http://www. crd. york. ac. 
uk/ PROSPERO/
Background
Despite the introduction of new tests and 
guidelines for diagnosis of tuberculosis (TB), 
case detection of infected people or people 
with disease still remains far from optimal.1 2 In 
2014, the worldwide case detection rate of TB 
disease was only 63%.1 It is also approximated 
that 3 million cases are missed by health systems 
every year. The need to accurately identify 
persons with TB in a population is important 
in administering correct and timely treatment, 
in limiting the spread of TB especially the 
drug-resistant strains and in avoiding unneces-
sary mortality. In 2013, a total of 480 000 people 
developed multidrug-resistant TB with 210 000 
associated deaths.3
One reason for the poor case detection of 
TB could be poor implementation of guide-
lines to diagnose TB. Such guidelines aim to 
assist health workers to identify infected or 
diseased patients by recommending tests and 
testing algorithms to be used depending on a 
patient’s symptoms and healthcare resources 
and setting. However, quantitative studies have 
shown that health workers adhere poorly to 
TB algorithms, policies or guidelines.4–7 For 
example, a secondary analysis of trial data 
on health worker adherence to a TB diag-
nostic algorithm in South Africa, found that 
the algorithm was only adhered to in 24% of 
HIV-infected patients with an initial negative 
TB test.6 Poor health worker adherence or 
implementation of TB diagnostic guidelines 
has also been reported in other low-income,7 8 
middle-income4 9 10 and high-income settings.11
To explain the possible reasons for poor 
implementation or adherence to health 
guidelines, primary qualitative studies done 
in various settings have cited possible reasons 
including health stakeholders (healthcare 
workers, managers, patients), health system or 
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Protocol
Strengths and limitations of the study
 ► We have prepared this protocol in line with PRISMA_P 
(Preferred Reporting Items for Systematic Reviews 
and Meta-analysis Protocols) guidelines.
 ► We will use rigorous methods to systematically 
identify, appraise and synthesise the qualitative 
evidence.
 ► To minimise selection and reviewer bias, two review 
authors will perform study identification and data 
extraction independently.
 ► This review will be limited by what is reported in the 
included studies. We will not seek original data.
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contextual barriers.11–16 Systematically collating the find-
ings of primary qualitative studies exploring barriers and 
facilitators could advance the evidence base and guide 
implementation approaches. To our knowledge, there is no 
qualitative systematic review exploring factors affecting the 
implementation of TB diagnostic guidelines. Such a review 
could help explain the perspectives from various settings or 
help generate more generalisable theories or hypotheses.17 
A Cochrane review looking at the effectiveness of interven-
tions to increase TB case detection is currently under way.18 
Our qualitative review may provide greater insights to why 
those interventions succeed or fail. This information may 
help guide the implementation of TB diagnostic guidelines 
and also the design of effective interventions to improve 
uptake of these guidelines.
oBjecTive
Through this review, we aim to identify, appraise and 
synthesise qualitative evidence to describe the barriers and 
facilitators to implementing guidelines on TB diagnosis.
criteria for considering studies for this review
We shall include studies that fulfil the following criteria:
Types of studies
In this systematic review of qualitative studies we will 
include studies that employ qualitative study designs, for 
example, case studies, grounded theory, phenomenolog-
ical studies, mixed methods and ethnographic designs. Any 
study that uses qualitative methods for data collection such 
as interviews (individual and focus group), observation and 
qualitative methods for data analysis such as thematic anal-
ysis will be included. We will exclude studies that collect 
data using qualitative methods but analyse the data quan-
titatively. We shall exclude studies with included comments 
from quantitative surveys, editorials and opinion pieces.
Types of participants
We will include studies that report on the perspectives of 
health workers, health managers, policymakers, patients, 
activists, academics and other stakeholders that we will 
come across in the studies towards implementation of 
guidelines for TB diagnosis. We define health workers as 
‘all people engaged in actions whose primary intent is to 
enhance health’ as recommended by the WHO.19
Type of setting
We will include studies from any geographical setting glob-
ally and from any setting where TB diagnosis is conducted 
including healthcare facilities, the community and during 
home visits.
Types of interventions
To enhance the applicability of our review, we will include 
studies that focus on the implementation of a guideline 
about any diagnostic test, algorithm or strategy for any 
form of TB including latent TB infection, pulmonary 
or extrapulmonary disease, drug susceptible or drug 
resistance disease. We will include any qualitative study 
that explores the guideline implementation of any diag-
nostic test, algorithm or strategy whether it is the main 
focus of the study or nested within the study. We will 
focus on the implementation of guidelines that form 
part of the specific context’s standard of care. We will 
apply a broad definition of the term guideline described 
as ‘systematically developed statements to assist practi-
tioner and patient decisions about healthcare for specific 
clinical circumstances.’20 Studies that explore the imple-
mentation of a diagnostic test (eg, Xpert MTB/RIF) or 
algorithm (eg, smear negative algorithms) or process 
regardless of whether the term guideline is explicitly 
mentioned will also be included. Examples of guideline 
implementation strategies or interventions include those 
targeted at healthcare organisations (organisational 
culture, continuous quality improvement), health-
care workers (education, training, audit and feedback, 
reminders, patient-mediated interventions) and patients 
(reminders, financial incentives).21 22
Types of outcome measures
The phenomena of interest in this review are attitudes, 
perspectives and experiences of health stakeholders (eg, 
health workers, managers, policymakers, patients) when 
implementing guidelines on TB diagnosis.
Search methods for identification of studies
We will develop a search strategy using guidelines recom-
mended by the Cochrane Qualitative Research Methods 
group23 and search multiple electronic sources and 
include studies without date or language restrictions.
The search strategy will incorporate the key terms: 
‘guidelines’, ‘tuberculosis’, ‘implementation’, ‘attitudes’ 
and their associated synonyms. We will search electronic 
databases including: MEDLINE, EMBASE, TRIP, The 
Cochrane Library, CINAHL (Cumulative Index to Nursing 
and Allied Health Literature) and several regional data-
bases (African Index Medicus, Index Medicus for the 
Eastern Mediterranean Region, INDMED, HERDIN, Thai 
Index Medicus, LILACS). The detailed MEDLINE search 
strategy available in box 1 will be tailored to different 
databases.
We will also search other resources such as the reference 
list of included studies, grey literature including govern-
ment or non-governmental organisation reports, and 
websites that contain evidence on TB diagnosis including 
the WHO, Evidence-based Tuberculosis Diagnosis and 
the International Union Against TB and Lung Disease. 
We will also conduct forward citation searching of rele-
vant articles using related articles features on PubMed 
and Google scholar. To access unpublished literature, we 
will contact relevant experts in the field of TB and imple-
mentation of guidelines.
To minimise selection bias, two authors will inde-
pendently screen the search outputs for potentially 
eligible studies, compare their selections, and resolve 
disagreements by discussion and consensus. These authors 
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will also independently screen the full text of potentially 
eligible articles to check if the articles fulfil the inclusion 
criteria defined by the types of studies, participants, inter-
vention, setting and outcomes. The search results will be 
presented in the form of a flow diagram as recommended 
by the Preferred Reporting Items for Systematic Reviews 
and Meta-analysis (PRISMA).24
data extraction and analysis
Drawing from the Supporting the Use of Research 
Evidence (SURE) framework,25 we shall develop a 
structured and standardised data extraction form 
for extracting data from the selected studies. The 
SURE framework focuses on barriers to implementing 
health systems interventions and includes elements 
on knowledge and skills, health system challenges, 
and social and political constraints (online supple-
mentary appendix 1). To ensure the integrity of the 
assessment, we will pilot the data extraction form 
on at least three studies identified from the list of 
potentially eligible studies. We will extract data about 
the first author, publication year, journal, language, 
participant group (cadre of health worker), setting 
(country, rural/urban, type of health facility), inter-
vention (type, description and recommendation of 
guideline, the test, test strategy or algorithm and form 
of TB focused by the guideline), research methods 
(method of data collection and analysis, framework 
used) and outcomes (reported barriers and facilitators 
and related themes). Two authors will independently 
extract the data. Any disagreements will be resolved 
through discussion or by a third reviewer.
assessment of quality of included studies
There is currently no consensus on standard criteria to 
be applied to assess the methodological quality of quali-
tative studies. For our review, we will use an adaptation of 
the Critical Appraisal Skills Programme (CASP) quality 
assessment tool for qualitative studies.17 This adapted 
tool was developed based on the authors’ experience in 
synthesising qualitative studies on adherence to TB treat-
ment. In this light, it may be applicable to our focus on 
TB diagnostic guidelines. Other systematic reviews of 
qualitative studies have also used this tool.26 27 Two review 
authors will independently apply the CASP tool. Any 
disagreements will be resolved though discussion or by 
a third author. Our adapted CASP checklist will have the 
following eight questions which will be scored as either 
Yes, No or Unclear:
1. Is the study setting or context described sufficiently?
2. Is the sampling method clearly described?
3. Is the data collection method clearly described?
4. Is the method for data analysis clearly described 
and appropriate?
5. Are the findings or conclusions made supported by 
adequate evidence?
6. Is there evidence of reflexivity?
7. Does this study demonstrate sensitivity to ethical 
concerns?
8. Any other concerns?
Studies will not be excluded on the basis of quality. 
However, we will apply the CASP tool as part of the 
Confidence in the Evidence from Reviews of Qualitative 
research (CERQual) approach for assessing confidence in 
the findings of the systematic review (see below).
Box 1 Search strategy (for MEDLINE)
1. ‘Tuberculosis/diagnosis’ OR ‘Tuberculosis/epidemiology’ OR 
‘Tuberculosis/prevention and control’[Mesh]
2. ((‘Tuberculosis, Multidrug-Resistant/diagnosis’[Mesh] OR 
‘Tuberculosis, Multidrug-Resistant/epidemiology’[Mesh] OR 
‘Tuberculosis, Multidrug-Resistant/prevention and control 
"[Mesh])))
3. ((tuberculosis OR TB OR MDR-TB OR XDR-TB) AND (diagnosis OR 
diagnostic* OR detection OR RDT* OR screen*) [Title/Abstract])
4. (tuberculosis OR TB OR MDR-TB OR XDR-TB) AND (‘active case 
finding’ or ACF) [Title/Abstract]
5. (tuberculosis OR TB OR MDR-TB OR XDR-TB) AND ‘point of care’ 
[Title/Abstract]
6. ‘Latent Tuberculosis’[Mesh] AND (diagnosis OR diagnostic* OR 
detection OR RDT* OR screen* or ‘active case finding’ or ACF or 
‘point of care’ [Title/Abstract])
7. 1 or 2 or 3 or 4 or 5 or 6
8. ‘Qualitative Research’[MeSH] OR ‘Interviews as Topic’[MeSH]
9. ‘Attitude of Health Personnel’ [Mesh]
10. Qualitative or survey or ‘focus group*’ or interview* or 
questionnaire or experience* or ‘mixed method*”[Title/Abstract]
11. ‘Health services’[MeSH] OR ‘Delivery of Health Care’[Mesh] OR 
‘Health Services Accessibility’[Mesh] OR ‘Patient Acceptance of 
Health Care’[Mesh] OR ‘Health Status Disparities’[Mesh] or ‘Health 
Knowledge, Attitudes, Practice’[Mesh]
12. ‘Health Personnel/education’[Mesh] OR ‘Health Personnel/
manpower’[Mesh] OR ‘Health Personnel/organization and 
administration’[Mesh] OR ‘Health Personnel/psychology’[Mesh] 
OR ‘Health Personnel/statistics and numerical data’[Mesh] OR 
‘Health Personnel/utilization’[Mesh] or Health Personnel/standards 
[Mesh]
13. ‘Healthcare utilization’ OR ‘healthcare seeking’ [Title/Abstract]
14. ‘Patients’[Mesh] or ‘patient compliance’ [MeSH] or ‘Consumer 
Participation’[Mesh] or (stakeholder* or provider* or ‘health 
manager*’ or “community-based or academic* or advocacy [Title/
Abstract]
15. barrier* or delay* or facilitat* or enable* or limit* or drawback* 
or challeng* or stigma* or failure* or constrain* or factor* or 
challenge* or attitude* or perspective* [Title/Abstract]
16. ‘Delayed Diagnosis’[Mesh] or ‘Delayed diagnosis’ [Title/Abstract] 
or ‘Diagnostic delay*’ [Title/Abstract]
17. 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16
18. guideline* or ‘best practice*’ or evidence or EBM) AND (adher* or 
apply* or application or disseminat* or implement* or introduce* 
or uptake) [Title/Abstract])
19. Consensus OR Statement OR Algorithm [Title/Abstract]
20. ‘Guideline Adherence’[Mesh]
21. 18 or 19 or 20
22. 7 and 17 and 21
23. 22 NOT (case reports[pt] OR editorial[pt] OR comment[pt] OR 
practice guideline[pt])
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daTa SynTheSiS
To analyse and synthesise qualitative data, we will use 
the thematic framework analysis approach.23 27 Thematic 
synthesis is useful where the evidence is likely to be largely 
descriptive and will enhance our understanding of why 
the health stakeholders think, feel and behave as they do. 
We will follow the five stages of framework synthesis to 
synthesise our qualitative data:
Familiarisation with the data: The first author will begin 
with familiarisation of the data against the aims of the 
review and note recurrent themes across the studies.
Identifying a thematic framework: Instead of developing our 
own a priori framework, we will use the SURE thematic 
framework to guide our thematic analysis. However, we 
will adapt this framework based on the emerging themes 
from our analysis. This framework provides a detailed list 
of possible factors that could influence the implementa-
tion of an intervention.
Indexing: Two review authors will independently 
read the extracted information to search for themes 
according to the SURE framework and additional emer-
gent themes. The framework will be revised as new 
themes emerge. This will be done upon discussion and 
agreement by the entire author team. All studies will be 
read until there are no new emerging themes. Coding of 
the data will be done based on the themes identified in 
the data. Each primary study will be indexed using the 
codes related to the themes of the framework. Where 
appropriate, parts of the studies may be indexed with 
one or more codes.
Charting: We will sort the data by theme and present 
the themes in the form of an analysis table (chart). The 
columns and rows of the table will reflect the studies and 
related themes and enable us to compare findings of the 
studies across different themes and subthemes.
Mapping and interpretation: We will use the charts to 
define the identified concepts and map the range and 
nature of the phenomena. We will explore associations 
between the themes to help explain the findings better. 
We will map and interpret our findings in line with the 
review objectives and emerging themes.
We will present our findings as a ‘Summary of qualita-
tive findings’ table that will summarise our key findings, 
our confidence judgement for each finding and a related 
explanation of the assessment.
Subgroup analysis and investigation of heterogeneity
We will assess heterogeneity of findings or differences 
in views of the included participants by conducting 
subgroup analyses according to: type of stakeholder 
(eg, health worker, patient, manager, policymaker) 
and setting (low-income and middle-income countries 
vs high-income countries). We will also consider other 
axes that could emerge as important when synthesising 
the evidence such as urban/rural or high income/low 
income setting across both low/middle and high-income 
countries or cadre of health worker (clinicians vs nurses 
vs community workers).
assessment of confidence in the review findings
We will apply the CERQual approach to transparently 
assess our confidence in the findings of the systematic 
review.28 This approach draws on the principles of the 
Grading of Recommendations, Assessment, Develop-
ment and Evaluation approach. The CERQual approach 
assesses confidence in the review findings based on four 
components which include: the methodological limita-
tions of included studies, the relevance of the included 
studies to the review question, the coherence of the 
review findings and the adequacy of data contributing to 
the review findings.
Concerns with any of the four components will be 
noted for each review finding and taken into consider-
ation when making an overall CERQual assessment of 
confidence in that finding as either high, moderate, low 
or very low. The CERQual assessment and written justi-
fication will appear in a summary of qualitative findings 
table.
reporting of protocol and systematic review
We have prepared this protocol according to the reporting 
guideline: Preferred Reporting Items for Systematic 
Reviews and Meta-analysis Protocols (PRISMA-P).29 We 
will also use the PRISMA24 to report the findings of our 
review. Because PRISMA focuses on reporting of reviews 
of interventions we will use the relevant items to report 
findings of our qualitative review.
ethics and dissemination
This protocol has been registered with the International 
Prospective Register of Systematic Reviews (PROSPERO), 
registration number CRD42016039790. This review is 
a retrospective study, drawing on data that are publicly 
available and does not need to undergo a formal ethical 
review for approval. We will disseminate the findings of 
this review through publication in a peer-reviewed journal 
and via conference presentations. We shall also prepare a 
review summary using the SURE dissemination guides30 
and disseminate it to groups involved in the translation 
of TB guidelines into practice in South Africa. We will 
discuss the findings and applicability of our review in line 
with our review question, relevance to the implementa-
tion of guidelines for TB diagnosis and implications for 
future research.
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